Quoin Pharmaceuticals, Ltd.

Healthcare · Biotechnology · United States

Last price 4.54 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 21.81M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company’s lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic ...